Current Assets Zmiana Data
Agios Pharmaceuticals USD 833.83M 129.48M 2023-12
Almirall EUR 762.27M 209.56M 2023-06
Amarin USD 717.51M 11.02M 2023-09
Amgen USD 30.33B 18.14B 2023-12
Artemis Alpha GBP 4.91M 719K 2022-06
AstraZeneca USD 22.5B 338M 2023-09
Bayer EUR 37.53B 1.25B 2023-09
BioMarin Pharmaceutical USD 2.96B 780K 2023-12
Bluebird Bio USD 247.08M 40.9M 2023-09
Demant DKK 9.53B 495M 2023-06
Exelixis USD 1.44B 147.16M 2023-09
Galapagos EUR 3.96B 76.05M 2023-09
Genmab DKK 33.03B 3.28B 2023-09
GlaxoSmithKline GBP 21.24B 1.89B 2023-09
GN Store Nord DKK 10.06B 1.05B 2023-09
GRIFOLS EUR 6.45B 1.44B 2023-12
Hikma Pharmaceutical USD 2.18B 177M 2023-06
Insmed USD 929.06M 2.49M 2023-12
Lonza CHF 5.62B 92M 2023-06
Merck EUR 13.57B 547M 2023-09
Regeneron Pharmaceuticals USD 24.49B 5.85B 2023-12
Roche Holding CHF 30.98B 2.84B 2023-06
UCB EUR 3B 303M 2023-06



Genmab Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2024.